MX9405318A - Pirimidonas e imidazolinonas para tratamiento del choque. - Google Patents

Pirimidonas e imidazolinonas para tratamiento del choque.

Info

Publication number
MX9405318A
MX9405318A MX9405318A MX9405318A MX9405318A MX 9405318 A MX9405318 A MX 9405318A MX 9405318 A MX9405318 A MX 9405318A MX 9405318 A MX9405318 A MX 9405318A MX 9405318 A MX9405318 A MX 9405318A
Authority
MX
Mexico
Prior art keywords
shock
treatment
pyrimidones
imidazolinones
tnfó
Prior art date
Application number
MX9405318A
Other languages
English (en)
Inventor
Victoria L Cohan
Eric R Pettipher
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX9405318A publication Critical patent/MX9405318A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

El compuesto de la fórmula I: y sus sales de adición de ácidos aceptablesfarmacéuticamente, donde X, m, n, R1, R2, R3 y R4 como se definen aquí sonútiles en el tratamiento de choque y otros transtornos relacionados conTNFÓ-.
MX9405318A 1993-07-13 1994-07-12 Pirimidonas e imidazolinonas para tratamiento del choque. MX9405318A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/091,693 US5482944A (en) 1993-07-13 1993-07-13 Pyrimidones and imidazolinones for treatment of shock

Publications (1)

Publication Number Publication Date
MX9405318A true MX9405318A (es) 1995-01-31

Family

ID=22229174

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9405318A MX9405318A (es) 1993-07-13 1994-07-12 Pirimidonas e imidazolinonas para tratamiento del choque.

Country Status (12)

Country Link
US (1) US5482944A (es)
EP (1) EP0636369A1 (es)
JP (1) JP2899861B2 (es)
KR (1) KR950002763A (es)
CN (1) CN1105858A (es)
AU (1) AU6741294A (es)
CA (1) CA2127735A1 (es)
HU (1) HUT67598A (es)
IL (1) IL110243A0 (es)
MX (1) MX9405318A (es)
RU (1) RU94026088A (es)
ZA (1) ZA945032B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5563143A (en) * 1994-09-21 1996-10-08 Pfizer Inc. Catechol diether compounds as inhibitors of TNF release

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3315797A1 (de) * 1983-04-30 1984-10-31 Beiersdorf Ag, 2000 Hamburg Substituierte phenyl-2-(1h)-pyrimidinone, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
US4971959A (en) * 1987-04-14 1990-11-20 Warner-Lambert Company Trisubstituted phenyl analogs having activity for congestive heart failure
CZ280006B6 (cs) * 1989-11-13 1995-09-13 Pfizer Inc. Způsob přípravy opticky aktivního (2S) nebo (2R)-endobicyklo-2.2.1heptan-2-olu
WO1991007177A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders
EP0557408A4 (en) * 1990-11-06 1993-10-27 Smith-Kline Beecham Corporation Imidazolidinone compounds

Also Published As

Publication number Publication date
US5482944A (en) 1996-01-09
RU94026088A (ru) 1996-05-20
JPH08208473A (ja) 1996-08-13
JP2899861B2 (ja) 1999-06-02
CN1105858A (zh) 1995-08-02
IL110243A0 (en) 1994-10-21
ZA945032B (en) 1996-01-12
CA2127735A1 (en) 1995-01-14
HU9402081D0 (en) 1994-09-28
KR950002763A (ko) 1995-02-16
AU6741294A (en) 1995-01-27
HUT67598A (en) 1995-04-28
EP0636369A1 (en) 1995-02-01

Similar Documents

Publication Publication Date Title
AR007118A1 (es) 4(3h)-quinazolinonas 2,3 disustituidas y composiciones farmaceuticas que las contienen
ES2097872T3 (es) Fenilpirazolidinonas como agentes broncodilatadores y antiinflamatorios.
AP2002002637A0 (en) Novel piperazine
DK0562512T3 (da) Sulfonamidocarbonylpyridin-2-carboxylsyreamider samt deres anvendelse som lægemidler
PA8447801A1 (es) Derivados del acido hexanoico
ES2139638T3 (es) 1,4-piperazinas disustituidas para el tratamiento de las enfermedades del sistema nervioso central y de las enfermedades neuroendocrinas.
ES2096673T3 (es) Uso de sulfonamidas como medicamentos y nuevas sulfonamidas.
PA8442201A1 (es) Derivados de 6-fenilpiridil-2-amina
ES2166379T3 (es) 2-aminotetralinas sustituidas.
BRPI0408347A (pt) derivados de pirimidina
SV2002000197A (es) Nuevos derivados de biarileter utiles como inhibidores de la recaptacion de monoaminas ref. pc10602/20073/bb
TR199900486T2 (xx) Aziniloksi ve fenoksi-diaril-karbonasit t�revleri.
ES2101858T3 (es) Derivados de geneserina como inhibidores de colinesterasa.
AR024494A1 (es) Proceso para la preparacion de derivados de ciclopentano sustituido y novedosas estructuras cristalinas de los mismos
TR200102008T2 (tr) Serebral işemi profilaksı ve tedavisi için piridin türevlerinin kullanımı.
DE69530988T2 (de) Benzimidazolderivate mit dopaminerger wirkung
NO20014240D0 (no) C16-umettede FP-selektive prostaglandinanaloger
ES2124861T3 (es) Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa.
AR008244A1 (es) Compuestos heterociclicos, procedimiento para prepararlos, composiciones farmaceuticas que los comprenden, uso de dichos compuestos en la fabricacion de medicamentos, e intermediarios utiles en la preparacion de dichos compuestos
ES2175006T3 (es) N-(pirimidinil)-benzosulfonamidas como medicamentos.
ES2051954T3 (es) 2-aminotiazoles substituidos.
PT861250E (pt) Derivados de amidina e de isotioureia como inibidores de oxido nitrico sintase
ES2077878T3 (es) Derivados substituidos de amidas de aminoacidos, su obtencion y su empleo como fungicidas.
MX9405318A (es) Pirimidonas e imidazolinonas para tratamiento del choque.
AR027578A1 (es) Derivados de indano